Figure 2.
CCN3 enhances osteogenic factor expression in osteoblasts. (A,B) Osteoblasts were treated with CCN3 (10–100 ng/mL) for 24 h; mRNA and protein expression were examined by qPCR (A,B) and Western blot assay (C), respectively. Results are expressed as the mean ± S.E. * p < 0.05 as compared with the control group.